It has been discovered that LINC00261 has unique epigenetic and post-transcriptional regulation mechanisms that act as tumor suppressors in pancreatic cancer, which could be beneficial for pancreatic cancer targeted treatment (43). The gene discussed is LINC00261; the disease is pancreatic neoplasm.